alzheimer's glp-1 Role of glucagon-like peptide-1 receptor agonists in disease and Parkinson's disease | Journal of Biomedical Science GLP-1 Drugs May Help Prevent

This is inspired by pharmaceutical delivery technology, transferring pharma-quality methods to nutraceuticals

It accelerates aging

Some employers are implementing participation requirements such as lifestyle or nutrition programs, while others are evaluating temporary pauses or exclusions to offset expenses

Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk

The FDA labeling for Wegovy, Saxenda, and Zepbound includes warnings about monitoring for depression, suicidal thoughts, and suicidal behavior, which is particularly relevant for patients already taking antidepressants